论文部分内容阅读
本文对NIDDM患者、甲状腺功能异常患者、急性心肌梗塞患者血清甘胆酸水平进行了测定和分析。结果NIDDM患者血清CG（ng／ml）水平（325．14±748．09）、急性心肌梗塞患者（912．8±1485．2）、甲亢组（620．3±625．6），先天性甲低组（1384．2±1984．4）、后天性甲低组（407．6±445．8）均比对照组（121．6±72．6）增高（P＜0．001）。治疗后血清甘胆酸水平下降。说明上述几种疾病患者有肝功能损伤，提示对在肝脏代谢的药物慎用。
In this paper, patients with NIDDM, patients with thyroid dysfunction, patients with acute myocardial infarction serum glycocholic acid levels were measured and analyzed. Results The serum levels of CG (ng / ml) in NIDDM patients (325.14 ± 748.09), patients with acute myocardial infarction (912.8 ± 1485.2), hyperthyroidism (620.3 ± 625.6) (1384.2 ± 1984.4) and acquired hypothyroidism (407.6 ± 445.8) were higher than those in the control group (121.6 ± 72.6) (P <0.001). After treatment, serum glycocholic acid levels decreased. This shows that several patients with liver disease damage, suggesting caution in the liver metabolism of drugs.